$121 Million is the total value of New Leaf Venture Partners, L.L.C.'s 17 reported holdings in Q1 2023. The portfolio turnover from Q4 2022 to Q1 2023 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q1 2023 | ||||||||
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-05-11
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| DECIPHERA THERAPEUTICS INC | 27 | Q1 2024 | 44.4% |
| CHIMERIX INC | 25 | Q1 2023 | 20.9% |
| ARVINAS INC | 24 | Q2 2024 | 46.6% |
| CRINETICS PHARMACEUTICALS INC | 24 | Q2 2024 | 11.4% |
| SIERRA ONCOLOGY INC | 22 | Q2 2022 | 14.9% |
| ALECTOR INC | 22 | Q2 2024 | 4.6% |
| X4 PHARMACEUTICALS INC | 21 | Q2 2024 | 1.1% |
| HARPOON THERAPEUTICS INC | 20 | Q4 2023 | 20.0% |
| OBSEVA SA | 20 | Q4 2021 | 8.5% |
| AVROBIO INC | 20 | Q1 2023 | 1.7% |
View New Leaf Venture Partners, L.L.C.'s complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-20 |
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-14 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-11 |
| 13F-HR | 2023-02-06 |
| 13F-HR | 2022-11-10 |
| 13F-HR | 2022-08-09 |
View New Leaf Venture Partners, L.L.C.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.